Author: Shetty, Ashok K.; Shetty, Padmashri A.; Zanirati, Gabriele; Jin, Kunlin
Title: Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS Cord-id: yb8kuch5 Document date: 2021_9_9
ID: yb8kuch5
Snippet: Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome (ARDS) could diminish cytokine storm and lung damage. While these outcomes are significant, additional phase II/III trials are required to validate the efficacy of MSCs to improve the survival of COVID-19 patients with ARDS. Future studies also need to assess the efficacy of MSCs to prevent long COVID.
Document: Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome (ARDS) could diminish cytokine storm and lung damage. While these outcomes are significant, additional phase II/III trials are required to validate the efficacy of MSCs to improve the survival of COVID-19 patients with ARDS. Future studies also need to assess the efficacy of MSCs to prevent long COVID.
Search related documents:
Co phrase search for related documents- adjunct therapy and lung damage: 1, 2
- adjunct therapy and lung function: 1, 2, 3, 4
- adjunct therapy and lung lesion: 1, 2
- long covid and lung accumulate: 1
- long covid and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- long covid and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- long covid and lung regeneration: 1, 2
Co phrase search for related documents, hyperlinks ordered by date